Genomictree Inc. (KOSDAQ:228760)
27,450
+150 (0.55%)
Dec 30, 2025, 3:30 PM KST
Genomictree Market Cap
Genomictree has a market cap or net worth of 659.41 billion as of December 30, 2025. Its market cap has increased by 110.14% in one year.
Market Cap
659.41B
Enterprise Value
576.58B
Revenue
3.76B
Ranking
n/a
PE Ratio
n/a
Stock Price
27,450.00
Market Cap Chart
Since April 5, 2017, Genomictree's market cap has increased from 59.00B to 659.41B, an increase of 1,017.67%. That is a compound annual growth rate of 31.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 29, 2025 | 655.81B | 33.68% |
| Dec 30, 2024 | 490.60B | 0.78% |
| Dec 28, 2023 | 486.82B | 168.25% |
| Dec 29, 2022 | 181.48B | -32.87% |
| Dec 30, 2021 | 270.36B | -7.66% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Apr 5, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 78.97T |
| Celltrion | 39.67T |
| ALTEOGEN | 24.33T |
| ABL Bio | 10.99T |
| SK Biopharmaceuticals | 9.83T |
| Yuhan | 8.44T |
| HLB Co., Ltd. | 6.45T |
| LigaChem Biosciences | 6.36T |